Single Nucleotide Polymorphisms or SNPs are a most abundant, stable and simple base pair changes that occur in the genome. It is an important variation that can be used to describe many unsolved problems in modern medicine such as individual variation to disease response, differences in response to treatment, allergies to drug treatment, etc. Monogenic Mendalian diseases are very rear and most of the time the disease has complex multigenetic involvement. With the advancement of sequencing technologies SNP discovery is becoming fast, accurate and less expensive. As a result the availability of SNP data has become more abundant and is used to create SNPmap and SNPprofile. This SNP map and SNP profile helps to locate the genes that involve some complex diseases like diabetes, vascular diseases, and mental disorders and to describe individual variation in response to treatment as well as finding a drug target in pharmacogenomics. With such developments in Bioinformatics, the dream of "individualized treatment" is becoming a reality.
Background
With the advancement of new DNA sequencing technologies, 99% of the human genome is sequenced and now interest is turning to the evaluation of variation which can be seen in the human genome (1) . These variations can be single base-pair changes (SNP), insertion and deletion (Indel) or copy number variation (CNV). Variations of single nucleotides (A,T,C or G) at specific positions in the genome sequence that differs between members of the species or paired chromosomes in an individual are called Single Nucleotide Polymorphisms, or SNPs. These alterations of single nucleotides are considered as SNPs when they occur in at least 1% of the population. SNPs, which make up about 90% of all human genetic variation occurs every 100 to 300 bases along the three billion base pairs of human genome. SNPs are also evolutionarily stable, making them easier to follow in population studies (1) .
Although more than 99.9% of genomes of different individuals are identical, variations in these genomes are responsible for all the differences in a human. Variations in DNA sequence have a major impact on how humans respond to diseases; environmental factors such as bacteria, viruses, toxins and chemicals. Further, SNPs are directly associated with human response to drugs and other therapies. This makes SNPs a valuable tool for various biomedical research such as developing pharmaceutical products and medical diagnostics.
Due to the significance of SNPs, SNP discovery is one of the major fields in genomics where scientists have worked and created a SNP map of human genome. The Human Genome Project (2) The SNP Consortium or TCS project (3) , International HapMap project (4) and The Human Variome project (5) are worth studying. Scientists believe SNP maps will help them identify the multiple genes associated with complex condition such as cancer, diabetes, vascular disease, and some forms of mental illness (6) . These associations are difficult to establish with conventional gene hunting methods because a single altered gene may make only a small contribution to the disease. In addition to pharmacogenomic, diagnostic and biomedical research implications, SNP maps help identify thousands of additional markers in the genome (7) . These markers simplify navigation of the much larger genome map generated by HGP researchers.
Medical relevance of SNPs in the human genome
Identification of SNPs that contribute to susceptibility to common diseases will provide highly accurate diagnostic information that will facilitate early diagnosis, prevention, and treatment of human diseases. The biological and medical considerations are important, if not critical, in identifying high-risk individuals that are very likely to bear genetic variants which will predispose them to a particular disease, whereas, the low risk individuals may bear allelse that may protect them from disease. Therefore, it is important that such individuals with "extreme phenotypes" should be sequenced preferentially to identify phenotypically or medically relevant allelic variants. Therefore, various risks and phenotypes may have to be taken into account when modeling the SNP analysis. It should be certain that such biologically and medically informed approach would reduce the number of individuals needed to be sequenced based on their risks or protection, leading to an increased chance of identifying important variants.
Researchers have found that most SNPs are not responsible for a disease state because they are intergenic SNPs. Instead, they serve as biological markers for pinpointing a disease on the human genome map, as they are located near a gene found to be associated with a certain disease (7) .
It is a fact that, single gene disorders inherited according to Mendalian law are rare and most common diseases like diabetes are caused by multiple genes. Finding all of these genes is difficult. Recently, there has been focus on the idea that all of the genes involved can be traced by using SNPs (7) . By comparing the SNP patterns in affected and non-affected individuals, patients with diabetes and healthy controls can catalog the specific DNA variation that underlie susceptibility for diabetes.
Advancement of new sequencing technologies enables to sequence genomes of different individuals at low cost and these sequences are known as Personal Genomes. Today number of personal genomes are available and some of them are:
The complete genome of an individual Human (8) The Sequence of the Human Genome (9) The Diploid Genome Sequence of an Individual Human (10) The First Korean Genome (11) The Korean Individual Genome (AKI) (12) Chinese Genome (13) African Genome (14) 
Analysis of association between SNPs and diseases
Genetic polymorphisms contribute to variations in phenotypes, risk to certain diseases and response to drugs and the environment. Genome wide linkage analysis and positional cloning have been tremendously successful for mapping human disease genes that underlie monogenic Mendelian diseases (15) . But most common diseases (such as diabetes, cardiovascular diseases, and cancer) and clinically important quantitative traits have complex genetic architectures; a combination of multiple genes and interactions with environmental factors is believed to determine these phenotypes.
Genome wide association studies offer a promising approach for mapping associated loci. The completion of the human genome sequence (17) enabled the identification of millions of Single Nucleotide Polymorphisms (SNPs) (18) and the construction of a high density haplotype map (19) . These advances have set the stage for large scale genome wide SNP surveys for seeking genetic variations associated with or causative of a wide variety of human diseases.
SNP detection methodologies
Next generation massively parallel sequencing technologies provide ultra high thorughput at two orders of magnitude lower unit cost than capillary Sanger sequencing technology. One of the key applications of next generation sequencing is studying genetic variation between individuals using whole genome or target region re-sequencing (20) .
For more than two decades, Sanger sequencing and fluorescence based electrophoresis technologies have dominated the DNA sequencing field. DNA sequencing is the method of choice for novel SNP detection, using either a random shotgun strategy or PCR amplification of regions of interest. Most of the SNPs deposited in dbSNP were identified by these methods (21) . A key advantage of the utility of traditional Sanger sequencing is the availability of the universal standard of phred scores (22) for defining SNP detection accuracy in which the phred programme assigns a score to each base of the raw sequence to estimate an error probability.
With high thoroughput clone sequencing of shotgun libraries, a standard method for SNP detection (23) is to align the reads onto a reference genome and filter low quality mismatches according to their phred score known as the "neighborhood quality standard" (NQS) (24) . With direct sequencing of PCR amplified sequences from diploid samples, software, including SNPdetector (25) , novoSNP (26) , PolyPhred (27) , and PolyScan (28) have been developed to examine chromatogram files to detect heterozygous polymorphisms.
New DNA sequencing technologies which have recently been developed and implemented, such as the Illumina Genome Analyser (GA), Roche/454 FLX system, and AB SOLiD system, have significantly improved and dramatically reduced the cost as compared to capillary based electrophoresis systems (29) . In a single experiment using one Illumina GA, the sequence of approximately 100 million reads of up to 50 bases in length can be determined. This ultrahigh thoroughput makes next generation sequencing technologies particularly suitable for carrying out genetic variation studies by using large scale re-sequencing of siseable cohorts of individuals with a known reference (30) . Three humans have been sequenced using these technologies: James Watson's genome by 454 Life Sciences (Roche) FLX sequencing technology (31) , an Asian genome (32) , and an African genome (33) sequenced by Illumina GA technology. Additionally, given such sequencing advances, an international research consortium has formed to sequence the genomes of at least 1000 individuals to create the most detailed human genetic variation map to date. SNP detection methods for standard sequencing technologies are well developed. However, given distinct differences in the raw output data format from different next generation sequencing, novel methods for accurate SNP detection are essential. To meet these needs, the massively parallel Illumina GA technology, a method of consensus calling and SNP detection have developed. The Illumina platform uses a "phred" like quality score system to measure the accuracy of each sequenced base pair. Using this, we calculated the likelihood of each genotype at each site based on the alignment of short reads to a reference genome together with the corresponding sequencing quality scores. The statistical analysis is carried out for genotype with the highest posterior probability at each site using a Bayesian method. The Bayesian method has been used for SNP calling for traditional Sanger sequencing technology (34) and has also been introduced for the analysis of next generation sequencing data (35) . In the method presented here, we have taken into account the intrinsic bias or errors that are common in Illumina GA sequencing data and recalibrated the quality values for use in inferring consensus sequence.
They evaluated this SNP detection method using the Asian genome sequence, which has 36× high quality data (32) . The evaluation demonstrated that their method has a very low false call rate at any sequencing depth, and excellent genome coverage in high depth data, making it very useful for SNP detection in Illumina GA re-sequencing data at any sequencing depth. This methodology and the developed software described in this report have been integrated into the Short Oligonucleotide Alignment Programme (SOAP) package (35) and named "SOAPsnp" to indicate its functionality for SNP detection using SOAP short read alignment results as input.
SOAPsnp: A de novo short reads assembler
SOAPsnp is a member of the SOAP (Short Oligonucleotide Analysis Package) (36) . The programme is a re-sequencing utility that can assemble consensus sequence for the genome of a newly sequenced individual based on the alignment of the raw sequencing reads on the known reference. The SNPs can then be identified on the consensus sequence through the comparison with the reference. In the first Asian genome re-sequencing project, evalution of SOAPsnp result on Illumina HapMap 1M BeadChip Duo genotyping sites shows great accuracy. Over 99% of the genotyping sites are covered at over 99.9% consistency. Further, PCR plus Sanger sequencing of the inconsistent SNP sites confirmed majority of the SOAPsnp results.
Other methods

Polybayes Software
PolyBayes is a computer programme for the automated analysis of single nucleotide polymorphism (SNP) discovery in redundant DNA sequences. The primary motivation for its development is to provide a general and reliable tool for the discovery of genetic variation and automated analysis of SNP discovery in redundant DNA sequences (37) .
ssahaSNP This is a software package which can detect homozygous SNPs and indels on a eukaryotic genome scale from millions of shotgun reads. Matching seeds of a few kmer words are found to locate the position of the read on the genome. Full sequence alignment is performed to detect base variations. Quality values of both variation bases and neighbouring bases are checked to exclude possible sequence base errors. To analyse polymorphism level in the genome, they used the package to detect indels from 20 million WGS reads against the draft WGS assembly. From the dataset, a total of 663,660 indels have been detected, giving an estimated average indel density at about one indel every 2.48 Kb. Distribution of indels length and variation of indel mapped times were also analysed (38) .
PbShort
PbShort is the working name for a new short read SNP and short INDEL discovery programme, a re-incarnation of the PolyBayes SNP discovery tool developed by Gabor Marth at Washington University. This version is specifically optimised for the analysis of large numbers (millions) of high throughput next generation sequencer reads, aligned to whole chromosomes of model organism or mammalian genomes.
The software takes advantage of "random" access to DNA read data and assembly information stored in binary files. Computer programmes for converting text format sequence files and assembly formats are packaged together with the SNP caller software (39) .
However, in the process of finding association between SNPs and human disease the exomsequencing has become more prominent (39) . Exome sequencing is more affordable than Whole Genome Sequencing (WGS) as well as several other advantages such as that by exome -sequencing can detect additional small variants missed by WGS.
